csirt@kutim:~/threat-intel/cve/CVE-2025-34233

Katalog CVE

CVSS 6.8 · Medium EPSS 0,59%

Kerentanan Server-Side Request Forgery (SSRF) pada vasion virtual appliance application, vasion virtual appliance host. Skor CVSS 3.1 6.8 (Medium) menurut NVD.

Deskripsi (NVD)

Vasion Print (formerly PrinterLogic) Virtual Appliance Host prior to version 25.1.102 and Application prior to version 25.1.1413 (VA/SaaS deployments) contain a protection mechanism failure vulnerability within the file_get_contents() function. When an administrator configures a printer’s hostname (or similar callback field), the value is passed unchecked to PHP’s file_get_contents()/cURL functions, which follow redirects and impose no allow‑list, scheme, or IP‑range restrictions. An admin‑level attacker can therefore point the hostname to a malicious web server that issues a 301 redirect to internal endpoints such as the AWS EC2 metadata service. The server follows the redirect, retrieves the metadata, and returns or stores the credentials, enabling the attacker to steal cloud IAM keys, enumerate internal services, and pivot further into the SaaS infrastructure. This vulnerability has been confirmed to be remediated, but it is unclear as to when the patch was introduced.

Rincian

Terbit di NVD
29 September 2025
Terakhir diubah
17 Juni 2026
Status NVD
Analyzed
CVSS 3.1
6.8 (Medium), sumber NVD
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:C/C:H/I:N/A:N · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-918: Server-Side Request Forgery (SSRF)
EPSS (30 hari)
0,59% peluang dieksploitasi; lebih tinggi dari 46,9% CVE lain

Produk dan versi terdampak

VendorProdukVersi terdampak
vasion virtual appliance application Semua versi sebelum 25.1.1413
vasion virtual appliance host Semua versi sebelum 25.1.102

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:11 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.